Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Liminatus Pharma, Inc. - Class A Common Stock (NQ:LIMN)

1.850 -0.140 (-7.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 507,687
Open 1.980
Bid (Size) 1.860 (3)
Ask (Size) 1.870 (2)
Prev. Close 1.990
Today's Range 1.810 - 1.980
52wk Range 1.810 - 33.66
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Wondering what's happening in today's pre-market session?
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-81.6%
-81.6%
1 Month
-53.4%
-53.4%
3 Month
-84.7%
-84.7%
6 Month
-81.6%
-81.6%
1 Year
-81.6%
-81.6%

More News

Read More
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
From Liminatus Pharma Inc.
Via GlobeNewswire
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital Strategies
From Liminatus Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
From Liminatus Pharma Inc.
Via GlobeNewswire
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy
From Liminatus Pharma Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Higher: S&P 500 Sees 'Average Gain Of 6.1%' In 2nd Half, Expert Says
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Carnival Posts Better-Than-Expected Earnings, Joins Liminatus Pharma, Coinbase Global, Uber And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Nektar Therapeutics Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Liminatus Pharma, Inc. - Class A Common Stock publicly traded?
Yes, Liminatus Pharma, Inc. - Class A Common Stock is publicly traded.
What exchange does Liminatus Pharma, Inc. - Class A Common Stock trade on?
Liminatus Pharma, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock?
The ticker symbol for Liminatus Pharma, Inc. - Class A Common Stock is LIMN on the Nasdaq Stock Market
What is the current price of Liminatus Pharma, Inc. - Class A Common Stock?
The current price of Liminatus Pharma, Inc. - Class A Common Stock is 1.850
When was Liminatus Pharma, Inc. - Class A Common Stock last traded?
The last trade of Liminatus Pharma, Inc. - Class A Common Stock was at 09/15/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.